What we are working on?
Focused ultrasound is a revolutionary non-invasive medical therapy. It sends sound waves from outside of the skull to mm-sized brain regions in any depth to create neurons stimulation or inhibition.
We have developed a stationary focused ultrasound system. We plan to develop the world's first wearable ultrasonic brain stimulator to replace current invasive Deep Brain Stimulators or DBS. DBS has FDA approval for Parkinson, Epilepsy, OCD, and Essential Tremor.
Focused ultrasound has shown promising results in these condition and, in general, for over 30 neurologic and psychiatric conditions. The problems with DBS are infection, bleeding, stroke, death and coma in case of MRI use, 10-year survival rate of 51%, and high cost of neurosurgery. Non-invasive ultrasonic alternative will solve these problems.
We started as university research at the University of California - Berkeley in 2015. YektaSonics was formed to introduce a focused ultrasound phased array in 2017. Later, we started to introduction of a non-invasive ultrasonic brain stimulator, and in particular, the world's first wearable brain stimulator to replace current invasive DBS (Deep Brain Stimulators).
We have the vision of non-invasive ultrasonic brain stimulator. This non-invasive technology can replace current DBS systems, for conditions such as Parkinson and Epilepsy. There are 30 neurologic and psychiatric disorders that focused ultrasound can potentially treat.
We currently have a novel phased array system with pure sine outputs. Our ultrasonic brain stimulator technology will be a wearable miniaturized brain stimulator that sits outside of skull to treat neurologic and psychiatric patients.
We have a novel ultrasound phased array system. The array has pure sine output, with fine phase and power control on its output, delivering high power to end transducers. This video shows the device in the lab:
The final ultrasonic brain stimulator will be a wearable battery powered device which sends sound waves to the finely localized brain regions for therapeutic purposes. This goal will be achieved via arrangement of tiny transducers on the patient skull with no neurosurgery.
This revolutionary technology will replace current invasive DBS systems. This video shows the importance of brain treatment for movement disorder, and invasiveness of neurosurgery.
National Science Foundation, Bay Area I-Corps Node Award Number 1643295
University of California-Berkeley Incubator Citris Foundry Cohort Selected Team 2020.
A FUS manufacturer and Included in 2021 State of the Field report.